A new study by researchers from Marshall University and the University of Missouri highlights how exosomes—tiny vesicles ...
For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...
Rakovina Therapeutics Unveils Preclinical Data at the AACR - World’s Premier Cancer Research Forum
Rakovina will present two abstracts at the meeting, the first: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence , explores the use of ...
CNS Pharmaceuticals (CNSP) announced the primary analysis of its clinical trial evaluating Berubicin, the first anthracycline demonstrated to ...
Mia Love, the first Black Republican woman elected to Congress, died three years after being diagnosed with glioblastoma, a ...
Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...
In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...
A novel blood test evaluating protease activity identified 85% of early-stage pancreatic cancer samples. The test could be used for other cancer types, as well. A novel, rapid blood test ...
Health and Me on MSN9d
Blood-Brain Barrier Dysfunction Linked To Down SyndromeResearchers of a new study have discovered that DSRD patients showed signs of neuroinflammation and blood-brain barrier ...
Vascular dementia occurs when blood vessels that deliver blood to the brain become damaged. Our blood contains oxygen and nutrients that help the brain cells to work properly. When blood vessels are ...
Teddi Mellencamp has shared the next step in her brain cancer battle. The 43-year-old Real Housewives of Beverly Hills alum is now undergoing immunotherapy. Immunotherapy is a type of cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results